Press Release
Westchester Medical Center Launches $25 Million “Possible Starts Here” Campaign; Transformative Critical Care Tower Rising to Serve the Hudson Valley
October 1, 2025
WMCHealth launched the $25M “Possible Starts Here” campaign to complete the Brenda Fareri Pavilion, a 162,000-sq-ft critical care tower in Valhalla. Opening 2026, it will expand advanced ICU, stroke, cardiac, and trauma care for the Hudson Valley.
Press Release
WMCHealth Expands Cancer-Fighting Technology with Acquisition of Ion Robotic-Assisted Bronchoscopy System
September 24, 2025
WMCHealth has introduced the Ion robotic-assisted bronchoscopy system, enabling minimally invasive, highly precise lung biopsies. This technology improves early detection, diagnosis, and treatment options for lung cancer patients in the Hudson Valley.
Press Release
WMCHealth Network Expands Commitment to Hudson Valley Community by Assuming Full Ownership and Operation of Bon Secours Charity Health Systems Hospitals
September 18, 2025
Transition underscores WMCHealth’s commitment to long-term stability, clinical excellence and innovation in community-based care. WMCHealth has served as the primary operator of all three hospitals and their associated facilities since entering a joint partnership with BSMH in 2015 VALHALLA, N.Y. (September 18, 2025) – Westchester Medical Center Health Network (WMCHealth) and Bon Secours Mercy HealthContinue reading "WMCHealth Network Expands Commitment to Hudson Valley Community by Assuming Full Ownership and Operation of Bon Secours Charity Health Systems Hospitals"
Press Release
WMCHealth Network Appoints Peter G. Paige, MD, MMM, CPE, FACEP, as Inaugural Chief Clinical Officer
September 12, 2025
WMCHealth appoints Peter G. Paige, MD, as its first Chief Clinical Officer. Dr. Paige will lead quality, safety, and clinical excellence across WMCHealth’s nine-hospital network, advancing its mission as a model in academic healthcare.
Press Release
Westchester Medical Center Named GammaTile® Center of Excellence
September 9, 2025
Westchester Medical Center has been named a GammaTile® Center of Excellence by GT Medical Technologies, recognizing its leadership in using this cutting-edge treatment for brain tumors. As one of only five U.S. institutions to treat 50+ patients with GammaTile®, WMC delivers targeted radiation immediately after tumor removal, improving precision, reducing side effects, and enhancing recovery.
Press Release
New Study Brings Hope and Guidance for People Newly Diagnosed with Focal Epilepsy
September 8, 2025
A WMCHealth-led study finds most people with newly diagnosed focal epilepsy can achieve seizure freedom, but it often takes over a year and multiple treatments. The research offers hope, clearer expectations, and highlights the value of specialized care.
Press Release
Good Samaritan Hospital’s Bloodless Surgery Program Achieves 41% Reduction in Blood Transfusions
September 8, 2025
Good Samaritan Hospital, part of WMCHealth, cut red blood cell transfusions by 41% since 2017, over six times the national average. Led by Dr. Richard Evans, the Bloodless Medicine Program improves patient outcomes and serves as a model for other hospitals.
Press Release
Doctors Perform First Robotic Cardiac Procedure at Westchester Medical Center
August 28, 2025
Westchester Medical Center successfully performed its first robotic cardiac surgery, removing a heart mass through a small incision. The minimally invasive approach enables faster recovery, fewer complications, and marks a new era in advanced heart care.
Press Release
WMCHealth Trauma Chief Tapped to Shape National Standards for Lifesaving Care
August 14, 2025
Dr. Kartik Prabhakaran, Director of Trauma at Westchester Medical Center, has been appointed an ACS national site reviewer, recognizing his leadership in advancing trauma care standards nationwide and reinforcing WMCHealth’s role as a regional leader.
Press Release
Westchester Medical Center First in Region to Perform Groundbreaking TAMBE Procedure
August 13, 2025
Westchester Medical Center is the first in Hudson Valley to perform TAMBE, an FDA-approved, minimally invasive procedure for thoraco-abdominal aortic aneurysms, offering safer, faster recovery than open-heart surgery for high-risk patients.